Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

844
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
844
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stabilizing PrBO<sub>4</sub> (B = Cr, V) Monazite Polymorphs by Phosphate Loading: Chemical Pressure Perspective with Insights into Optical and Thermochemical Oxygen-Storage Properties of 3d<sup>1</sup> (Cr<sup>5+</sup>).

Inorganic chemistry·2026
Same author

In Silico-Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors.

ChemMedChem·2026
Same author

An automated model for differential meet in the middle attacks on AndRX ciphers.

Scientific reports·2026
Same author

Characterization and control of air cell cushion behavior in different environments.

Journal of rehabilitation and assistive technologies engineering·2026
Same author

Outcomes of Open Versus Arthroscopic Anterior Talofibular Ligament Repair: An Updated Systematic Review and Meta-analysis.

Indian journal of orthopaedics·2026
Same author

The interplay between inflammation and oxidative stress in depression: pathogenic mechanisms and treatment approaches.

Molecular biology reports·2025

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K

Tuberculosis vaccine: time to look into future.

Sumit Chawla1, Dinesh Garg1, Ram Bilas Jain1

  • 1PGIMS; Community Medicine; Rohtak, Haryana India.

Human Vaccines & Immunotherapeutics
|November 16, 2013
PubMed
Summary

Tuberculosis (TB) impacts millions globally. A prime-boost vaccine strategy using BCG and MVA85A aims to improve immune response and protection against TB, addressing the need for better TB vaccines.

Keywords:
researchtuberculosisvaccine

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.9K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

9.8K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.9K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

9.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Tuberculosis (TB) remains a significant global health challenge, with millions of new cases annually.
  • Existing TB immunity, whether from infection or recovery, does not reliably prevent reinfection or reactivation.
  • Vaccines offer a crucial public health intervention by potentially reducing disease transmission (herd immunity) and protecting individuals.

Purpose of the Study:

  • To evaluate the efficacy of a prime-boost vaccination strategy using MVA85A as a booster to BCG for tuberculosis prevention.
  • To investigate if the MVA85A booster enhances the immune response and protection against TB compared to BCG alone.

Main Methods:

  • The study employs a prime-boost vaccination strategy, initiating with BCG (Bacille Calmette-Guérin) and followed by MVA85A as a booster.
  • This approach is based on the hypothesis that combining these vaccines will elicit a superior immune response.

Main Results:

  • The abstract does not contain specific results from the trial, but outlines the theoretical basis for the MVA85A booster's potential.

Conclusions:

  • There is a critical need for enhanced TB vaccine research and development to combat the global burden of tuberculosis.
  • Increased support, investment, and favorable environments for clinical trials are essential for the eventual adoption of new TB vaccines.